Beam Therapeutics Inc.
Tremor tracks 1 of its cancer trials.
Company-wide warning signs
These add points to every one of this company's trials.
None right now.
Trials
Key executives leaving
From the last 12 months of the company's SEC reports.
None found.
Insider trades (last 6 months)
“Insiders” are executives, board members, and big shareholders. Many of their sales are pre-planned: scheduled months ahead under a legal plan (called 10b5-1), so they usually say little. Tremor only counts sales that weren't pre-planned.
11 sales (2 not pre-planned) · 0 purchases
- Evans John M.CEO · Oct 16, 2026Sold 25,000 sharesabout $600 thousand · pre-planned
- Evans John M.CEO · Oct 15, 2026Sold 25,000 sharesabout $589 thousand · pre-planned
- Cavanagh Bethany JSVP, Finance and Treasurer · Oct 1, 2026Sold 187 sharesabout $5 thousand · pre-planned
- Simon AmyChief Medical Officer · Jul 27, 2026Sold 16,667 sharesabout $429 thousand · pre-planned
- Simon AmyChief Medical Officer · Jun 30, 2026Sold 373 sharesabout $13 thousand · pre-planned
- Evans John M.CEO · Jun 30, 2026Sold 23,100 sharesabout $791 thousand · pre-planned
- Evans John M.CEO · Jun 30, 2026Sold 1,900 sharesabout $66 thousand · pre-planned
- Evans John M.CEO · Jun 29, 2026Sold 13,421 sharesabout $472 thousand · pre-planned
- Evans John M.CEO · Jun 29, 2026Sold 11,579 sharesabout $416 thousand · pre-planned
- FMR LLCLarge shareholder · Jun 26, 2026Sold 251,488 sharesabout $8.9 million · not pre-planned
- FMR LLCLarge shareholder · Jun 25, 2026Sold 33,372 sharesabout $1.2 million · not pre-planned
Recent SEC filings
Public companies must report important news and their finances to the SEC, the US agency that oversees the stock market.
Money left
Coming soon: how many months of cash the company has, from its quarterly reports.